Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Agranulocytosis caused by dipyrone. Case reports].

F Castiglioni, M Broggini, E Baratelli

    La Clinica Terapeutica
    |August 15, 1989
    PubMed
    Summary

    Dipyrone can cause agranulocytosis, a serious condition, even after a single dose or with prolonged use. Patient education and physician vigilance are key to preventing this adverse drug reaction.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Assessing coverage of the monitoring framework of the Kunming-Montreal Global Biodiversity Framework and opportunities to fill gaps.

    Nature ecology & evolution·2025
    Same author

    Colorectal cancer patients-derived immunity-organoid platform unveils cancer-specific tissue markers associated with immunotherapy resistance.

    Cell death & disease·2024
    Same author

    Author Correction: Forearc carbon sink reduces long-term volatile recycling into the mantle.

    Nature·2019
    Same author

    Hypnotic communication for periprocedural analgesia during transcatheter ablation of atrial fibrillation.

    International journal of cardiology. Heart & vasculature·2019
    Same author

    Fluorinated porous organic frameworks for improved CO<sub>2</sub> and CH<sub>4</sub> capture.

    Chemical communications (Cambridge, England)·2019
    Same author

    Author Correction: Forearc carbon sink reduces long-term volatile recycling into the mantle.

    Nature·2019

    Area of Science:

    • Pharmacology
    • Hematology
    • Toxicology

    Background:

    • Dipyrone is a widely used analgesic and antipyretic medication.
    • Agranulocytosis is a severe adverse drug reaction characterized by a drastic reduction in neutrophils.
    • Understanding dipyrone's potential to induce agranulocytosis is crucial for patient safety.

    Observation:

    • Two distinct cases of dipyrone-induced agranulocytosis are presented.
    • The first case resulted from a single dipyrone administration.
    • The second case developed following prolonged dipyrone therapy.

    Findings:

    • The pathogenic mechanisms underlying dipyrone-induced agranulocytosis may involve immunologic and/or toxic pathways.
    • The study discusses the efficacy of various therapeutic interventions and supportive care measures.

    Related Experiment Videos

  • Both single and prolonged exposure to dipyrone can precipitate this hematologic emergency.

    • Implications:

    • Physician awareness and careful patient monitoring are essential for early detection and management.
    • Effective patient health education regarding dipyrone risks can contribute to prevention.
    • This highlights the importance of risk-benefit assessment for dipyrone use in clinical practice.